OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Lin Kang, Shilin Jin, Jiayi Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 458-473
Open Access | Times Cited: 64
Lin Kang, Shilin Jin, Jiayi Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 458-473
Open Access | Times Cited: 64
Showing 26-50 of 64 citing articles:
AAV-mediated GBA1 and GDNF rescue neurological defects in a murine model of neuronopathic Gaucher disease
Yuan Meng, Jiale Zhang, Ruifeng Fan, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102506-102506
Open Access
Yuan Meng, Jiale Zhang, Ruifeng Fan, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 2, pp. 102506-102506
Open Access
Advances in Optogenetics and Thermogenetics for Control of Non-Neuronal Cells and Tissues in Biomedical Research
Vera S. Ovechkina, Sofya K. Andrianova, Iana O. Shimanskaia, et al.
ACS Chemical Biology (2025)
Closed Access
Vera S. Ovechkina, Sofya K. Andrianova, Iana O. Shimanskaia, et al.
ACS Chemical Biology (2025)
Closed Access
Hurdles to healing: Overcoming cellular barriers for viral and nonviral gene therapy
Steffen Honrath, Michael Burger, Jean‐Christophe Leroux
International Journal of Pharmaceutics (2025), pp. 125470-125470
Open Access
Steffen Honrath, Michael Burger, Jean‐Christophe Leroux
International Journal of Pharmaceutics (2025), pp. 125470-125470
Open Access
AAV vectors trigger DNA damage response-dependent pro-inflammatory signalling in human iPSC-derived CNS models and mouse brain
Helena Costa Verdera, Vasco Meneghini, Zachary Fitzpatrick, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Helena Costa Verdera, Vasco Meneghini, Zachary Fitzpatrick, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Hippocampus-targeted BDNF gene therapy to rescue cognitive impairments of Alzheimer's disease in multiple mouse models
S. H. Tang, Wenshu Luo, Shihao Wu, et al.
Genes & Diseases (2025), pp. 101649-101649
Open Access
S. H. Tang, Wenshu Luo, Shihao Wu, et al.
Genes & Diseases (2025), pp. 101649-101649
Open Access
Unlocking the future: Precision oligonucleotide therapy for targeted treatment of neurodegenerative disorders
Naitik Jain, Amrita Arup Roy, Geethu Madhusoodanan, et al.
International Journal of Biological Macromolecules (2025) Vol. 310, pp. 143515-143515
Open Access
Naitik Jain, Amrita Arup Roy, Geethu Madhusoodanan, et al.
International Journal of Biological Macromolecules (2025) Vol. 310, pp. 143515-143515
Open Access
AAV delivery of GBA1 suppresses α-synuclein accumulation in Parkinson’s disease models and restores functions in Gaucher’s disease models
Takuro Okai, Sho Sato, Mugdha Deshpande, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0321145-e0321145
Open Access
Takuro Okai, Sho Sato, Mugdha Deshpande, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0321145-e0321145
Open Access
Removal of empty capsids from high‐dose adeno‐associated virus 9 gene therapies
William S. Kish, J Lightholder, Tamara Zeković, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 8, pp. 2500-2523
Open Access | Times Cited: 3
William S. Kish, J Lightholder, Tamara Zeković, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 8, pp. 2500-2523
Open Access | Times Cited: 3
Identification of new AAV vectors with enhanced blood-brain barrier penetration efficiency via organ-on-a-chip
Mengmeng Li, Yujian Zhong, Mingyang Zhu, et al.
The Analyst (2024) Vol. 149, Iss. 15, pp. 3980-3988
Closed Access | Times Cited: 3
Mengmeng Li, Yujian Zhong, Mingyang Zhu, et al.
The Analyst (2024) Vol. 149, Iss. 15, pp. 3980-3988
Closed Access | Times Cited: 3
Microglia targeting by adeno-associated viral vectors
Maria Stamataki, Björn Rissiek, Tim Magnus, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Maria Stamataki, Björn Rissiek, Tim Magnus, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles
María Buñuales, Angeles Garduno, Miguel Chillón, et al.
Gene Therapy (2024) Vol. 31, Iss. 9-10, pp. 455-466
Open Access | Times Cited: 3
María Buñuales, Angeles Garduno, Miguel Chillón, et al.
Gene Therapy (2024) Vol. 31, Iss. 9-10, pp. 455-466
Open Access | Times Cited: 3
Therapeutic Application and Structural Features of Adeno-Associated Virus Vector
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8464-8498
Open Access | Times Cited: 3
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8464-8498
Open Access | Times Cited: 3
PET reporter systems for the brain
Sridhar Goud Nerella, Michel Michaelides, Takafumi Minamimoto, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 11, pp. 941-952
Open Access | Times Cited: 8
Sridhar Goud Nerella, Michel Michaelides, Takafumi Minamimoto, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 11, pp. 941-952
Open Access | Times Cited: 8
Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy
Aleksandr Klinkovskij, М. В. Шепелев, Y. A. Isaakyan, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3333-3333
Open Access | Times Cited: 7
Aleksandr Klinkovskij, М. В. Шепелев, Y. A. Isaakyan, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3333-3333
Open Access | Times Cited: 7
Endothelial lincRNA-p21 alleviates cerebral ischemia/reperfusion injury by maintaining blood-brain barrier integrity
Yun-Hua Zhao, Yu Liang, Kang-Ji Wang, et al.
Journal of Cerebral Blood Flow & Metabolism (2024) Vol. 44, Iss. 9, pp. 1532-1550
Closed Access | Times Cited: 2
Yun-Hua Zhao, Yu Liang, Kang-Ji Wang, et al.
Journal of Cerebral Blood Flow & Metabolism (2024) Vol. 44, Iss. 9, pp. 1532-1550
Closed Access | Times Cited: 2
Challenges for gene therapy in the financial sustainability of health systems: a scoping review
Hugo Ossandon, Nicolás Armijo, Constanza Vargas, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Hugo Ossandon, Nicolás Armijo, Constanza Vargas, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Emerging therapies in hereditary ataxias
Mallory L S Eisel, Matthew K. Burns, Tetsuo Ashizawa, et al.
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 2
Mallory L S Eisel, Matthew K. Burns, Tetsuo Ashizawa, et al.
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 2
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47
Jessica Wiseman, Joseph M. Scarrott, João Alves-Cruzeiro, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 11, pp. 2882-2917
Open Access | Times Cited: 2
Jessica Wiseman, Joseph M. Scarrott, João Alves-Cruzeiro, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 11, pp. 2882-2917
Open Access | Times Cited: 2
Hydrogels and Nanogels - Applications in Medicine
IntechOpen eBooks (2023)
Open Access | Times Cited: 6
IntechOpen eBooks (2023)
Open Access | Times Cited: 6
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold?
Barbara Bettegazzi, Stefano Cattaneo, Michele Simonato, et al.
Molecular Diagnosis & Therapy (2023) Vol. 28, Iss. 1, pp. 5-13
Open Access | Times Cited: 6
Barbara Bettegazzi, Stefano Cattaneo, Michele Simonato, et al.
Molecular Diagnosis & Therapy (2023) Vol. 28, Iss. 1, pp. 5-13
Open Access | Times Cited: 6
Gene therapy of adeno‐associated virus (AAV ) vectors in preclinical models of ischemic stroke
Jing Wang, Mengna Zhu, Jingyi Sun, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 12, pp. 3725-3740
Open Access | Times Cited: 5
Jing Wang, Mengna Zhu, Jingyi Sun, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 12, pp. 3725-3740
Open Access | Times Cited: 5
rAAV2-Mediated Restoration of GALC in Neural Stem Cells from Krabbe Patient-Derived iPSCs
Guoshuai Tian, Chunyu Cao, Shuyue Li, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 624-624
Open Access | Times Cited: 5
Guoshuai Tian, Chunyu Cao, Shuyue Li, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 624-624
Open Access | Times Cited: 5
Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis
Marcela Salazar Werner, Shweta Aras, Ashleigh Morgan, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 766-777
Closed Access | Times Cited: 1
Marcela Salazar Werner, Shweta Aras, Ashleigh Morgan, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 766-777
Closed Access | Times Cited: 1
Taking the knife to neurodegeneration: a review of surgical gene therapy delivery to the CNS
Andrea Perera, Olivier Brock, Aminul I. Ahmed, et al.
Acta Neurochirurgica (2024) Vol. 166, Iss. 1
Open Access | Times Cited: 1
Andrea Perera, Olivier Brock, Aminul I. Ahmed, et al.
Acta Neurochirurgica (2024) Vol. 166, Iss. 1
Open Access | Times Cited: 1
AAV vectors trigger DNA damage responses and STING-dependent inflammation in human CNS cells
Helena Costa Verdera, Vasco Meneghini, Zachary Fitzpatrick, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Helena Costa Verdera, Vasco Meneghini, Zachary Fitzpatrick, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
